The Crosstalk of PTGS2 and EGF Signaling Pathways in Colorectal Cancer
Colorectal cancer (CRC) is now the second-leading cause of cancer deaths in the USA. Colorectal cancer progression and metastasis depends on the orchestration of the aberrant signaling pathways that control tumor cell proliferation, survival and migration/invasion. Epidemiological, clinical, and ani...
Main Authors: | Dingzhi Wang, Dianren Xia, Raymond N. DuBois |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2011-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/3/4/3894/ |
Similar Items
-
Next-Generation Sequencing of PTGS Genes Reveals an Increased Frequency of Non-synonymous Variants Among Patients With NSAID-Induced Liver Injury
by: María Isabel Lucena, et al.
Published: (2019-02-01) -
Knockdown of PTGS2 by CRISPR/CAS9 System Designates a New Potential Gene Target for Melanoma Treatment
by: Giuseppe Ercolano, et al.
Published: (2019-12-01) -
Evaluation of Glycosylated PTGS2 in Colorectal Cancer for NSAIDS-Based Adjuvant Therapy
by: Roberta Venè, et al.
Published: (2020-03-01) -
Assessment of the impact of PTGS1, PTGS2 and
CYP2C9 polymorphisms on pain, effectiveness and
safety of NSAID therapies
by: Miriam Dawidowicz, et al.
Published: (2020-11-01) -
Transcriptomic analysis of differential gene expression reveals an increase in COX2 levels during in vitro canine herpesvirus infection
by: Jacqueline Kazue Kurissio, et al.
Published: (2018-10-01)